Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine

Infection and Immunity

Volumn 66, Issue 3, 1998, Pages 959-965

  Næss, Lisbeth Meyer ^a   Oftung, Fredrik ^a   Aase, Audun ^a   Wetzler, Lee M ^b   Sandin, Randi ^a   Michaelsen, Terje E ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL OUTER MEMBRANE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANE VESICLE; MEMORY CELL; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE; VACCINATION;

EID: 0031911353     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.3.959-965.1998     Document Type: Article

References (37)

1. Ada, G. L. 1990. The immunological principles of vaccination. Lancet 335: 523-526.
2. Akbar, A. N., L. Terry, A. Timms, P. C. L. Beverly, and G. Janossy. 1988. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T-cells. J. Immunol. 140:2171-2178.
3. Barlow, A. K., J. E. Heckels, and I. N. Clarcke. 1989. The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins. Mol. Microhiol. 3: 131-139.
4. Bjune, G., E. A. Høiby, J. K. Grønnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A.-K. Lindbak, H. Nøkleby E. Rosenqvist, L. K. Solberg, O. Closs, J. Eng, L. O. Frøholm, A. Lystad, L. S. Bakketeig, and B. Hareide. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
5. Blake, M. S., and E. C. Gotschlich. 1982. Purification and partial characterization of the major outer membrane proteins of Neisseria gonorrhoeae. Infect. Immun. 36:277-283.
6. Blake, M. S., and E. C. Gotschlich. 1986. Functional and immunological properties of pathogenic Neisseria surface proteins, p. 377-400. In M. Inouye (ed.), Bacterial outer membranes as model systems. John Wiley & Sons, Inc., New York, N.Y.
7. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T-cell costimulation. Immunity 2:555-559.
8. Bøyum, A, 1968. Separation of leukocytes from blood and hone marrow. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):108.
9. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Bronst, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, B. Kuipers, and J. Poolman. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
10. + T-cells throughout life, from newborns to centenarians: implications for T-cell memory. Mech. Ageing Dev. 86:173-195.
11. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Frøholm, A.-K. Lindbak, B. Møgster, E. Namork, U. Rye, G. Stabbetorp, R. Winsnes, B. Aase, and O. Closs. 1991. Production, characterization and control of MenB-Vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-80.
12. + lymphocytes in physically active adults. Eur. J. Immunol. 23: 2704-2706.
13. Goldschneider, I., M. L. Lepow, E. C. Gotschlich, F. T. Mauck, F. Bachl, and M. Randolph. 1973. Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J. Infect. Dis. 128:769-776.
14. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1307-1349.
15. Gray, D. 1993. Immunological memory. Annu. Rev. Immunol. 11:49-77.
16. Guttormsen, H.-K., L. M. Wetzler, and C. O. Solberg. 1994. Humoral immune response to the class 1 outer membrane protein during the course of meningococcal disease. Infect. Immun. 62:1437-1443.
17. Guttormsen, H.-K., L. M. Wetzler, and A. Næss. 1993. Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect. Immun. 61:4734-4742.
18. + T-cells from CD45Ra to CD45R0 is accompanied by cell activation and proliferation. Cytometry 19:343-352.
19. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C. L. Law, W. C. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643-5652.
20. McGuinness, B., A. K. Barlow, I. N. Clarke, J. E. Farley, A. Anilionis, J. T. Poolman, and J. E. Hecksls, 1990. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. J. Exp. Med. 171: 1871-1882.
21. Melancon, J., R. A. Murgita, and I. W. Devoe. 1983. Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens. Infect. Immun. 42:471-479.
22. Merkensclager, M., L. Terry, R. Edwards, and P. C. L. Beverley. 1988. Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for the differential CD45 expression in T cell memory formation. Eur. J. Immunol. 18:1653-1661.
23. Meyer Næss, L., E. Rosenqvist, E. A. Høiby, and T. E. Michaelsen. 1996. Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards. J. Immunol. Methods 196: 41-49.
24. Paulnock, D. M. 1992. Macrophage activation by T cells. Curr. Opin. Immunol. 4:344-349.
25. Peeters, C. C. A. M., H. C. Rümke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kuipers, P. van der Ley, and J. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
26. Peltola, H., P. H. Mäkelä, H. Käythy, H. Jousimies, E. Herva, K. Hällström, A. Sivonen, O.-V. Renkonen, O. Pettay, V. Karanko, P. Ahvonen, and S. Sarna. 1977. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297:686-691.
27. Rosenqvist, E., E. A. Høiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Rønnild, G. Bjune, and H. Nøkleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
28. Rosenqvist, E., S. Harthug, L. O. Frøholm, E. A. Høiby, K. Bøvre, and W. D. Zollinger. 1988. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection. J. Clin. Microbiol. 26: 1543-1548.
29. Saukkonen, K., M. Leinonen, H. Abdillahi, and J. T. Poolman. 1989. Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7:325-328.
30. Stulnig, T., C. Maczek, G. Böck, O. Majdic, and G. Wick. 1995. Reference intervals for human peripheral blood lymphocyte subpopulations from 'healthy' young and aged subjects. Int. Arch. Allergy Immunol. 108:205-210.
31. Tsai, C.-M. 1986. The analysis of lipopolysaccharide vaccines by silver staining following SDS-polyacrylamide gel electrophoresis. J. Biol. Stand. 14: 25-33.
32. Wetzler, L. M., Y. Ho, and H. Reiser. 1996. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183:1151-1159.
33. Wetzler, L. M., M. S. Blake, K. Barry, and E. C. Gotschlich. 1992. Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes and blebs isolated from rmp deletion mutants. J. Infect. Dis. 166:551-555.
34. Wiertz, E. J. H. J., A. Delvig, E. M. L. M. Donders, H. F. Brugghe, L. M. A. van Unen, H. A. M. Timmermans, M. Achtman, P. Hoogerhout, and J. T. Poolman. 1996. T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Ope, and PorA proteins. Infect. Immun. 64:298-304.
35. Wiertz, E. J. H. J., J. A. M. van Gaans-van den Brink, G. M. T. H. Schreuder, A. A. M. Termijtelen, P. Hoogerhout, and J. Poolman. 1991. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. J. Immunol. 147:2012-2018.
36. Wyle, F. E., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunological response in man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-522.
37. Zepp, F., M. Knuf, P. Habermehl, H. J. Schmitt, C. Rebsch, P. Schmidtke, R. Clemens, and M. Slaoui. 1996. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:4078-4084.